Home » Topics » Disease categories and therapies » Infection

Infection
RSS

TerraGen and Schering-Plough Research Institute establish collaborative agreement

Dec. 16, 1998

Another market introduction for imiquimod

Dec. 15, 1998

FDA approves expanded indication for CytoGam

Dec. 14, 1998

Broad-spectrum, water-soluble antiviral agent produced by Streptomyces discovered in Japan

Dec. 10, 1998

Pfizer produces novel erythromycins using precursor-directed biosynthetic technology

Dec. 10, 1998

Micrologix Biotech initiates phase I trial in U.S. with MBI-226

Dec. 10, 1998

LY-303366: therapeutic and prophylactic efficacy in pulmonary aspergillosis in neutropenic animals

Dec. 9, 1998

Water-soluble antifungal agents enter the pipeline at Takeda

Dec. 8, 1998

Japanese lab prepares new, broad-spectrum carbapenems

Dec. 7, 1998

Potent antifungal triazoles reported by Sankyo

Dec. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.